Health & pharma PFE NYSE Pharmaceutical Preparations

Pfizer

≈$33BTotal federal contracts
24Awards
8SEC filings (tracked)

Pfizer is one of the world's largest pharmaceutical companies, developing and manufacturing vaccines and medicines across many areas; it became widely known for its COVID-19 vaccine (with BioNTech).

It has deep federal ties through emergency R&D, procurement, and stockpiling (e.g., BARDA) and public health insurance. Drug development involves long timelines and regulation (FDA approval), and managing patent expirations (the patent cliff) is a perennial challenge.

What the data shows

  • Across our collection, federal contracts total $32,995,728,343 (24 awards), spanning 3 awarding agencies. The largest is Department of Defense ($27,702,056,069, ~84% of the total).
  • Awards are concentrated in a single agency.
  • Also: 8 SEC filings tracked.

Federal contracts (USAspending)

Amount Awarding agency Scope (original)
≈$12.55B Department of Defense /Department of the Army AWARD OF 10M TREATMENT COURSES OF ORAL PROTEASE INHIBITOR PF-07321332
≈$11.11B Department of Defense /Department of the Army COVID-19 VACCINE PRODUCTION
≈$4.15B Agency for International Development /Agency for International Development COVID-19 VACCINES FOR INTERNATIONAL DONATION
≈$4.04B Department of Defense /Department of the Army COVID-19 ADULT MDV VACCINE
≈$1.03B Department of Health and Human Services /Centers for Disease Control and Prevention IGF::OT::IGF 2017 VACCINES FOR CHILDREN
≈$68.4M Department of Health and Human Services /Office of Assistant Secretary for Preparedness and Response IGF::OT::IGF
≈$22M Department of Health and Human Services /Office of Assistant Secretary for Preparedness and Response TRAUNCHE 2 PHARMACEUTICALS
≈$5.8M Department of Health and Human Services /Centers for Disease Control and Prevention IGF::OT::IGF 2016 VFA - MERCK
≈$5.1M Department of Health and Human Services /Centers for Disease Control and Prevention 2017 ADULT VACCINES
≈$2.3M Department of Health and Human Services /Centers for Disease Control and Prevention PFIZER VACCINE STORAGE AND ROTATION IGF::OT::IGF FOR OTHER FUNCTIONS

→ AI-related federal spending ranking→ Defense contract ranking

Sources of funding (by agency)

The main agencies funding this company and cumulative amounts, from this site's collected contract data. Click an agency for details.

Federal contract awards over time (past 8 fiscal years)

Federal contract awards to Pfizer has fallen about 100% from FY2017 to FY2025 (≈$636.1M to ≈$1.4M).

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2025
Fiscal yearAwarded
FY2025≈$1.4M
FY2023≈$1.93B
FY2022≈$16.67B
FY2021≈$13.32B
FY2020≈$45.6M
FY2019≈$14.7M
FY2018≈$401.6M
FY2017≈$636.1M

Total federal contract awards (award types A–D) to this company per fiscal year (starting October). Source: USAspending. May be revised.

SEC filings (EDGAR)

→ SEC filing feed

Timeline

Events tied to this entity, newest first, from the data this site tracks.

  1. 2026-05-15 Contract Department of Health and Human Services ↗ ≈$543K
  2. 2026-05-05 Filing Current report (8-K) ↗ 8-K
  3. 2026-05-05 Filing Quarterly report (10-Q) ↗ 10-Q
  4. 2026-04-27 Filing Current report (8-K) ↗ 8-K
  5. 2026-03-12 Filing Proxy statement (DEF 14A) ↗ DEF 14A
  6. 2026-02-26 Filing Annual report (10-K) ↗ 10-K
  7. 2026-02-03 Filing Current report (8-K) ↗ 8-K
  8. 2025-08-26 Contract Department of Defense ↗ ≈$787K
  9. 2025-02-18 Contract Department of Health and Human Services ↗ ≈$1.2M
  10. 2024-09-30 Contract Department of Health and Human Services ↗ ≈$2.2M
  11. 2024-08-26 Contract Department of Defense ↗ ≈$925K
  12. 2023-08-24 Contract Department of Defense ↗ ≈$674K

Based on real dates within this site's collected set (contracts = start date / filings = filing date / rules = publication date). Not exhaustive.

FAQ

What kind of company is Pfizer?
One of the world's largest pharmaceutical firms, researching, developing, and making drugs and vaccines.
How is it tied to government?
Deeply, through government vaccine procurement, emergency R&D, FDA approval, and public health insurance.
What is its key challenge?
Replenishing its pipeline ahead of patent expirations (the patent cliff) on flagship drugs.

Sources (primary)

Entity ID (UEI)MHBQULRMEEJ5

This page is an independent organization that joins the U.S. official data below. Verify the exact, latest, and complete details with each official source.

Disclaimer: This site independently summarizes and classifies information based on official data sources. Always verify the latest and accurate information with the official sources. Content on finance, health, legal, and security is information, not advice. This site is not an official website of the U.S. government.